🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #348

Cancer - Press review (January 14, 2012) – Revue de presse (14 janvier 2012)

#348
From: SciMedWeb
Date: Sat, 14 Jan 2012 10:31
201 lines
9862 bytes
Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review  (January 14, 2012) – Revue de presse (14 janvier 2012)


Discovered: Mutation for Hereditary Prostate Cancer
Occurs in Less Than 2% of Affected Men.
By Nick Mulcahy. In Medscape
http://www.medscape.com/viewarticle/756711

Does Deodorant Ingredient Affect Breast Cancer Risk?
Small study finds suspect chemical even in women who never used the
product, further muddying the debate.
By Kathleen Doheny. In U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2012/01/12/does-deodorant-ingredient-affect-breast-cancer-risk

New Prostate Cancer Gene Mutation Discovered
After decades of work, researchers have discovered a new gene (HOXB13)
variant linked with a higher risk of developing hereditary prostate
cancer.
By Catherine Pearson. In Huffington Post
http://www.huffingtonpost.com/2012/01/11/prostate-cancer-gene-mutation_n_1199553.html

U.S. Life Expectancy Rises as Homicides Hit Lowest Since 1962
U.S. life expectancy climbed to a new high in 2010 as fewer people
died from heart disease and cancer, and homicide was no longer among
the 15 leading causes of death, the Centers for Disease Control and
Prevention said.
By Molly Peterson. In Bloomberg
http://www.bloomberg.com/news/2012-01-11/u-s-life-expectancy-climbs-as-homicide-cancer-deaths-decline.html

Uncertainty Over Use of GnRH Agonists in Breast Cancer
Infertility as a result of chemotherapy for breast cancer is not
improved with the use of a gonadotropin-releasing hormone (GnRH)
agonist (triptorelin), according to a new study.
By Zosia Chustecka. In Medscape Today
http://www.medscape.com/viewarticle/756813

Improvements in cancer research
Cancer Research UK Chief Executive Harpal Kumar sheds light on the
need for continued research to improve prevention, screening and
treatment.
In Public Service
http://www.publicservice.co.uk/feature_story.asp?id=17556

Lab-made tissue picks up the slack of Petri dishes in cancer research
New research demonstrates that previous models used to examine cancer
may not be complex enough to accurately mimic the true cancer
environment. Using oral cancer cells in a three-dimensional model of
lab-made tissue that mimics the lining of the oral cavity, the
researchers found that the tissue surrounding cancer cells can
epigenetically mediate, or temporarily trigger, the expression or
suppression of a cell adhesion protein associated with the progression
of cancer. These new findings support the notion that drugs that are
currently being tested to treat many cancers need to be screened using
more complex tissue-like systems, rather than by using conventional
petri dish cultures that do not fully manifest features of many
cancers.
In ScienceCodex
http://www.sciencecodex.com/read/labmade_tissue_picks_up_the_slack_of_petri_dishes_in_cancer_research-84189

Sharing Breast Cancer Results With Children Is Popular
An investigation published online in CANCER, a peer-reviewed journal
of the American Cancer Society has discovered that many parents share
their breast cancer test results with their children, even if they are
very young. Furthermore, the researchers discovered that the majority
of parents believe that their children are not distressed when they
find out about the test results.
By Grace Rattue. In Medical News Today
http://www.medicalnewstoday.com/articles/240142.php

ISG15: A novel therapeutic target to slow breast cancer cell motility
Interferon-stimulated gene 15 (ISG15), a ubiquitin like protein, is
highly elevated in a variety of cancers including breast cancer. How
the elevated ISG15 pathway contributes to tumorigenic phenotypes
remains unclear and is the subject of a study published in the January
2012 issue of Experimental Biology and Medicine.
In EurekAlert.
http://www.eurekalert.org/pub_releases/2012-01/sfeb-ian011112.php

Bach's charms soothe edgy prostate patients
A good set of headphones and a little Bach may ease the pain and
anxiety of getting a prostate biopsy, according to a newly published
study by Duke Cancer Institute researcher.
By Jay Price. In Vancouver Sun
http://www.vancouversun.com/health/Bach+charms+soothe+edgy+prostate+patients/5977799/story.html

Selectively stopping glutathione sensitizes brain tumors to
chemotherapy
Brain cancer cells are particularly resistant to chemotherapy — toxins
enter the cells, but before the toxins can kill, cancer cells quickly
pump them back outside. In fact, brain cancer cells are even better
than healthy cells at cleaning themselves. This means that when hit
with chemotherapy, healthy cells tend to die before brain cancer
cells. Especially in the brain, killing healthy cells is bad.
In Medical Xpress
http://medicalxpress.com/news/2012-01-glutathione-sensitizes-brain-tumors-chemotherapy.html



Découverte du premier gène mutant clé dans le cancer hérité de la
prostate
Après vingt ans d'effort, des chercheurs américains ont découvert la
première mutation génétique majeure liée à une nette augmentation du
risque de cancer héréditaire de la prostate, selon leurs travaux parus
mercredi dans le New England Journal of Medicine. Ce gène mutant rare
accroît de dix à vingt fois le risque de cancer de la prostate chez
les hommes les plus jeunes dans les familles affectées. Dans Le Monde
http://www.lemonde.fr/planete/article/2012/01/12/decouverte-du-premier-gene-mutant-cle-dans-le-cancer-herite-de-la-prostate_1628523_3244.html

Habiter près d'une centrale nucléaire favoriserait la leucémie chez
l'enfant‎
Selon une étude publiée dans l'International Journal of Cancer, les
cas de leucémies seraient deux fois plus fréquents chez les enfants
vivants à proximité d'une centrale nucléaire. Les scientifiques
refusent cependant d'en tirer des conclusions définitives.
Par Denis Delbecq. Dans L’Express.
http://www.lexpress.fr/actualite/sciences/sante/habiter-pres-d-une-centrale-nucleaire-favoriserait-la-leucemie-chez-l-enfant_1070801.html

14-3-3a: un gène qui freine le cancer du sein
Un travail publié en ligne dans Cancer Discovery fournit une nouvelle
preuve convaincante selon laquelle le gène 14-3-3a empêche la
progression des tumeurs.
Dans Techno-Science.net
http://www.techno-science.net/?onglet=news&news=9969

Le nombre de cancers baisse aux Etats-Unis, un million de décès évités
depuis 1990
Plus d'un million de décès ont été évités aux Etats-Unis depuis le
début des années 1990 grâce à la baisse du nombre de cancers, en
particulier du sein, du poumon, de la prostate et du colon, selon un
rapport publié mercredi par l'organisation américaine contre le
cancer.
AFP
http://www.google.com/hostednews/afp/article/ALeqM5gb97IqK6WXuwCxIcxHG42ZdNMaQA?docId=CNG.ecb7583686915eaf5bf0188a2f93b0b9.9e1

Cancers et prothèses mammaires: quand le doute ronge
Aucun lien de causalité n’a été démontré, mais les autorités
sanitaires françaises sont profondément embarrassées.
Par Jean-Yves Nau. Dans Slate.fr
http://www.slate.fr/story/47635/protheses-mammaires-cancer

Molécule innovante : Léon Bérard part à l'assaut de l'AKT
L'ARC et l'Inca financent un essai clinique évaluant une nouvelle
thérapie ciblée dans le lymphome. Cet essai a été conçu et promu par
le Centre Léon Bérard de Lyon. Fabien Calvo répond à Futurapolis.
Par Gérard Desportes. Dans Le Point.fr
http://www.lepoint.fr/futurapolis/sante/molecule-innovante-leon-berard-part-a-l-assaut-de-l-akt-10-01-2012-1417404_431.php






Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix – InTextoResearch – Baelen  (01/2012)
Technical Details
Message-ID: <0d826f93-6c5b-4166-b185-d1b920a49fde@v14g2000vbc.googlegroups.com>
Path: arc1-ca.pugleaf.net!cj8ni95663bkb.0!nntp.google.com!news2.google.com!postnews.google.com!v14g2000vbc.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: f5500,2beaf88a19569a4b,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.204.129.78 with SMTP id n14mr305410bks.5.1326537201705;
        Sat, 14 Jan 2012 02:33:21 -0800 (PST)
Path: arc1-ca.pugleaf.net!cj8ni95663bkb.0!nntp.google.com!news2.google.com!postnews.google.com!v14g2000vbc.googlegroups.com!not-for-mail
From: SciMedWeb <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press review  (January 14, 2012) – Revue de presse (14 janvier 2012)
Date: Sat, 14 Jan 2012 02:31:39 -0800 (PST)
Organization: http://groups.google.com
Lines: 201
Message-ID: <0d826f93-6c5b-4166-b185-d1b920a49fde@v14g2000vbc.googlegroups.com>
NNTP-Posting-Host: 81.247.51.220
Mime-Version: 1.0
X-Trace: posting.google.com 1326537201 32674 127.0.0.1 (14 Jan 2012 10:33:21 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 14 Jan 2012 10:33:21 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: v14g2000vbc.googlegroups.com; posting-host=81.247.51.220; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-Google-Web-Client: true
X-Google-Header-Order: UHALERCNK
X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.10.229 Version/11.60,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable